<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK320989" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK320989/" /><meta name="ncbi_pagename" content="Nuclear Gene-Encoded Leigh Syndrome Overview - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Nuclear Gene-Encoded Leigh Syndrome Overview - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Nuclear Gene-Encoded Leigh Syndrome Overview" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/10/01" /><meta name="citation_author" content="Shamima Rahman" /><meta name="citation_author" content="David Thorburn" /><meta name="citation_pmid" content="26425749" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK320989/" /><meta name="citation_keywords" content="Arginine-hydroxylase NDUFAF5, mitochondrial" /><meta name="citation_keywords" content="Cytochrome b-c1 complex subunit 8" /><meta name="citation_keywords" content="Cytochrome c oxidase assembly protein COX15 homolog" /><meta name="citation_keywords" content="Cytochrome c oxidase subunit NDUFA4" /><meta name="citation_keywords" content="Dihydrolipoyl dehydrogenase, mitochondrial" /><meta name="citation_keywords" content="FAD-dependent oxidoreductase domain-containing protein 1" /><meta name="citation_keywords" content="Leucine-rich PPR motif-containing protein, mitochondrial" /><meta name="citation_keywords" content="Methionyl-tRNA formyltransferase, mitochondrial" /><meta name="citation_keywords" content="Mitochondrial chaperone BCS1" /><meta name="citation_keywords" content="NADH dehydrogenase (ubiquinone) complex I, assembly factor 6" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial" /><meta name="citation_keywords" content="NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial" /><meta name="citation_keywords" content="Protein PET100 homolog, mitochondrial" /><meta name="citation_keywords" content="Protein SCO2 homolog, mitochondrial" /><meta name="citation_keywords" content="Protoheme IX farnesyltransferase, mitochondrial" /><meta name="citation_keywords" content="Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial" /><meta name="citation_keywords" content="Surfeit locus protein 1" /><meta name="citation_keywords" content="Tetratricopeptide repeat protein 19, mitochondrial" /><meta name="citation_keywords" content="Translational activator of cytochrome c oxidase 1" /><meta name="citation_keywords" content="BCS1L" /><meta name="citation_keywords" content="COX10" /><meta name="citation_keywords" content="COX15" /><meta name="citation_keywords" content="DLD" /><meta name="citation_keywords" content="FOXRED1" /><meta name="citation_keywords" content="LRPPRC" /><meta name="citation_keywords" content="MTFMT" /><meta name="citation_keywords" content="NDUFA1" /><meta name="citation_keywords" content="NDUFA10" /><meta name="citation_keywords" content="NDUFA12" /><meta name="citation_keywords" content="NDUFA2" /><meta name="citation_keywords" content="NDUFA4" /><meta name="citation_keywords" content="NDUFA9" /><meta name="citation_keywords" content="NDUFAF2" /><meta name="citation_keywords" content="NDUFAF5" /><meta name="citation_keywords" content="NDUFAF6" /><meta name="citation_keywords" content="NDUFS1" /><meta name="citation_keywords" content="NDUFS2" /><meta name="citation_keywords" content="NDUFS3" /><meta name="citation_keywords" content="NDUFS4" /><meta name="citation_keywords" content="NDUFS7" /><meta name="citation_keywords" content="NDUFS8" /><meta name="citation_keywords" content="NDUFV1" /><meta name="citation_keywords" content="PET100" /><meta name="citation_keywords" content="SCO2" /><meta name="citation_keywords" content="SDHA" /><meta name="citation_keywords" content="SURF1" /><meta name="citation_keywords" content="TACO1" /><meta name="citation_keywords" content="TTC19" /><meta name="citation_keywords" content="UQCRQ" /><meta name="citation_keywords" content="Nuclear Gene-Encoded Leigh Syndrome" /><meta name="citation_keywords" content="Overview" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Nuclear Gene-Encoded Leigh Syndrome Overview" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Shamima Rahman" /><meta name="DC.Contributor" content="David Thorburn" /><meta name="DC.Date" content="2015/10/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK320989/" /><meta name="description" content="Leigh syndrome (or subacute necrotizing encephalomyelopathy) is characterized by decompensation (often with elevated lactate levels in blood and/or CSF) during an intercurrent illness. It is typically associated with psychomotor retardation or regression, often followed by transient or prolonged stabilization or even improvement, but inevitably resulting in eventual progressive neurologic decline, typically occurring in stepwise decrements. Neurologic manifestations include hypotonia, spasticity, movement disorders (including chorea), cerebellar ataxia, and peripheral neuropathy." /><meta name="og:title" content="Nuclear Gene-Encoded Leigh Syndrome Overview" /><meta name="og:type" content="book" /><meta name="og:description" content="Leigh syndrome (or subacute necrotizing encephalomyelopathy) is characterized by decompensation (often with elevated lactate levels in blood and/or CSF) during an intercurrent illness. It is typically associated with psychomotor retardation or regression, often followed by transient or prolonged stabilization or even improvement, but inevitably resulting in eventual progressive neurologic decline, typically occurring in stepwise decrements. Neurologic manifestations include hypotonia, spasticity, movement disorders (including chorea), cerebellar ataxia, and peripheral neuropathy." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK320989/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/leigh-nucl-ov/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK320989/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89D400E0417511000000000113007D.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK320989_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK320989_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/leopard/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mga3/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK320989_"><span class="title" itemprop="name">Nuclear Gene-Encoded Leigh Syndrome Overview</span></h1><p class="contrib-group"><span itemprop="author">Shamima Rahman</span>, FRCP, FRCPCH, PhD and <span itemprop="author">David Thorburn</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK320989_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK320989_ai__"><div class="contrib half_rhythm"><span itemprop="author">Shamima Rahman</span>, FRCP, FRCPCH, PhD<div class="affiliation small">Professor of Paediatric Metabolic Medicine<br />Genetics and Genomic Medicine Programme<br />UCL Institute of Child Health and Great Ormond Street Hospital<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@namhar.amimahs" class="oemail">ku.ca.lcu@namhar.amimahs</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">David Thorburn</span>, PhD<div class="affiliation small">NHMRC Principal Research Fellow, Murdoch Children's Research Institute and Genetic Health Services Victoria<br />Royal Children's Hospital<br />Department of Paediatrics<br />University of Melbourne<br />Melbourne, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.ude.ircm@nrubroht.divad" class="oemail">ua.ude.ircm@nrubroht.divad</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 1, 2015</span>.</p><p><em>Estimated reading time: 24 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="leigh-nucl-ov.Summary" itemprop="description"><h2 id="_leigh-nucl-ov_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Leigh syndrome (or subacute necrotizing encephalomyelopathy) is characterized by decompensation (often with elevated lactate levels in blood and/or CSF) during an intercurrent illness. It is typically associated with psychomotor retardation or regression, often followed by transient or prolonged stabilization or even improvement, but inevitably resulting in eventual progressive neurologic decline, typically occurring in stepwise decrements. Neurologic manifestations include hypotonia, spasticity, movement disorders (including chorea), cerebellar ataxia, and peripheral neuropathy.</p><p>Extraneurologic manifestations may include hypertrophic cardiomyopathy, hypertrichosis, anemia, renal tubulopathy, liver involvement, ptosis, and muscle weakness. Onset is typically between ages three and 12 months; about 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals die by age three years, most often as a result of respiratory or cardiac failure. Later onset (including in adulthood) and long-term survival may occasionally occur.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome is established in individuals with a characteristic clinical presentation, bilateral symmetric T<sub>2</sub>-weighted hyperintensities in the basal ganglia and/or brain stem on brain MRI, elevated lactate in blood and/or cerebrospinal fluid (CSF), and either identification of pathogenic variants in a specific nuclear gene or exclusion of mutation of mtDNA.</p><p>Note: The term "Leigh-like syndrome" is often used when clinical and other features strongly suggest Leigh syndrome but do not fulfill the stringent diagnostic criteria because of atypical or normal neuroimaging, normal blood and CSF lactate levels, atypical neuropathology, and/or incomplete evaluation.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome and Leigh-like syndrome are inherited in either an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> or <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Specific treatment is possible for the three nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh-like syndromes: biotin-thiamine-responsive basal ganglia disease (BTBGD), biotinidase deficiency, and coenzyme Q<sub>10</sub> deficiency caused by mutation of <i>PDSS2</i>. Supportive care for any of the causes of nuclear gene-encoded Leigh syndrome includes treatment of acidosis, seizures, dystonia, and cardiomyopathy with attention to nutritional status and psychological support for caregivers.</p><p><i>Prevention of primary manifestations:</i> Prevention of manifestations is possible for biotin-thiamine-responsive basal ganglia disease (BTBGD), biotinidase deficiency, and coenzyme Q<sub>10</sub> deficiency caused by mutation of <i>PDSS2</i>. See <i>Treatment of manifestations</i>.</p><p><i>Prevention of secondary complications:</i> Because anesthesia can potentially aggravate respiratory symptoms and precipitate respiratory failure, careful consideration should be given to its use and close monitoring prior to, during, and after its use.</p><p><i>Surveillance:</i> Affected individuals should be followed at regular intervals (typically every 6-12 months) to monitor progression and the appearance of new manifestations. Neurologic, ophthalmologic, audiologic, and cardiologic evaluations are recommended.</p><p><i>Agents/circumstances to avoid:</i> Sodium valproate, barbiturates, and dichloroacetate.</p></div></div><div id="leigh-nucl-ov.Definition"><h2 id="_leigh-nucl-ov_Definition_">Definition</h2><div id="leigh-nucl-ov.Clinical_Manifestations_of"><h3>Clinical Manifestations of Nuclear Gene-Encoded Leigh Syndrome</h3><p>Leigh syndrome (or subacute necrotizing encephalomyelopathy) is characterized by decompensation (often with elevated lactate levels in blood and/or CSF) during an intercurrent illness. It is typically associated with psychomotor retardation or regression, often followed by transient or prolonged stabilization or even improvement, but inevitably resulting in eventual progressive neurologic decline, typically occurring in stepwise decrements.</p><p>Neurologic manifestations include hypotonia, spasticity, movement disorders (including chorea), cerebellar ataxia, and peripheral neuropathy.</p><p>Extraneurologic manifestations may include hypertrophic cardiomyopathy, hypertrichosis, anemia, renal tubulopathy, liver involvement, ptosis, and muscle weakness.</p><p>Onset is typically between ages three and 12 months, frequently following a viral infection. About 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals die by age three years, most often as a result of respiratory or cardiac failure.</p><p>Later onset (including in adulthood) and long-term survival may occasionally occur.</p><p>Life expectancy and extraneurologic manifestations appear to be related, at least in part, to the underlying genetic defect [<a class="bk_pop" href="#leigh-nucl-ov.REF.wedatilake.2013.96">Wedatilake et al 2013</a>].</p></div><div id="leigh-nucl-ov.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis of Nuclear Gene-Encoded Leigh Syndrome</h3><p>Establishing the diagnosis of nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome requires the following [<a class="bk_pop" href="#leigh-nucl-ov.REF.rahman.1996.343">Rahman et al 1996</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.lake.2015.482">Lake et al 2015</a>]:</p><ul><li class="half_rhythm"><div class="half_rhythm">Characteristic clinical presentation (see <a href="#leigh-nucl-ov.Definition">Definition</a>)</div></li><li class="half_rhythm"><div class="half_rhythm">Bilateral symmetric T<sub>2</sub>-weighted hyperintensities in the basal ganglia and/or brain stem on brain MRI</div></li><li class="half_rhythm"><div class="half_rhythm">Elevated lactate in blood and/or cerebrospinal fluid (CSF)</div></li><li class="half_rhythm"><div class="half_rhythm">Either identification of pathogenic variants in a specific nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or exclusion of mutation of mtDNA</div><div class="half_rhythm">Note: If postmortem examination is performed, characteristic neuropathologic changes include: multiple focal symmetric necrotic lesions in the basal ganglia, thalamus, brain stem, dentate nuclei, and optic nerves. Histologically, lesions have a spongiform appearance and are characterized by demyelination, gliosis, and vascular proliferation. Although neuronal loss can occur, typically the neurons are relatively spared.</div></li></ul><p><b>Leigh-like syndrome.</b> The term "Leigh-like syndrome" is often used when clinical and other features strongly suggest Leigh syndrome but do not fulfil the stringent diagnostic criteria because of atypical or normal neuroimaging, normal blood and CSF lactate levels, atypical neuropathology (variation in the distribution or character of lesions or with the additional presence of unusual features such as extensive cortical destruction), and/or incomplete evaluation.</p></div><div id="leigh-nucl-ov.Prevalence_of_Nuclear_Gene"><h3>Prevalence of Nuclear Gene-Encoded Leigh syndrome</h3><p>Prevalence of nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome is approximately 1:40,000 [<a class="bk_pop" href="#leigh-nucl-ov.REF.rahman.1996.343">Rahman et al 1996</a>].</p></div></div><div id="leigh-nucl-ov.Causes"><h2 id="_leigh-nucl-ov_Causes_">Causes</h2><p>Nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome can be subdivided by <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> and gene: <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance (see <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig" rid-ob="figobleighnuclovTautosomalrecessiveleig">Table 1</a> and <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig_1/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig1" rid-ob="figobleighnuclovTautosomalrecessiveleig1">Table 2</a>) and <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance (see <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.xlinked_leigh_syndrome_a/?report=objectonly" target="object" rid-figpopup="figleighnuclovTxlinkedleighsyndromea" rid-ob="figobleighnuclovTxlinkedleighsyndromea">Table 3</a>). While pathogenic variants in more than 50 nuclear genes can cause nuclear gene-encoded Leigh syndrome, all but a few of these gene defects are associated with a very limited number of cases.</p><div id="leigh-nucl-ov.Autosomal_Recessive_Leigh"><h3>Autosomal Recessive Leigh Syndrome and Leigh-Like Syndromes</h3><p>Causes of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome (<a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig" rid-ob="figobleighnuclovTautosomalrecessiveleig">Table 1</a>) include mutation of genes encoding OXPHOS enzymes and their assembly factors; defects of mitochondrial DNA maintenance, gene expression, and protein synthesis; cofactor biosynthesis (lipoic acid and coenzyme Q<sub>10</sub>); mitochondrial membrane lipid remodeling; pyruvate dehydrogenase; biotinidase; vitamin transporters; and organic acidemias with accumulation of metabolites leading to secondary OXPHOS dysfunction.</p><p>Although mutation of a given <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> may lead to either "classic" Leigh syndrome or a Leigh-like syndrome, mutation of certain genes typically results in classic Leigh syndrome (<a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig" rid-ob="figobleighnuclovTautosomalrecessiveleig">Table 1</a>) and mutation of other genes typically causes Leigh-like syndromes or other clinical presentations and are only rarely associated with classic Leigh syndrome (<a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig_1/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig1" rid-ob="figobleighnuclovTautosomalrecessiveleig1">Table 2</a>).</p><div id="leigh-nucl-ov.T.autosomal_recessive_leig" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Autosomal Recessive Leigh Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__leigh-nucl-ov.T.autosomal_recessive_leig_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of AR LS caused by Mutation of This Gene</th><th id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Distinguishing Clinical Features</th><th id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="2" scope="col" colspan="1" headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" style="text-align:left;vertical-align:middle;">Reference</th></tr><tr><th headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3" id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">HCM</th><th headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3" id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic&#x000a0;<sup>1</sup></th><th headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3" id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other</th></tr></thead><tbody><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" colspan="6" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Complex I-deficient Leigh syndrome&#x000a0;<sup>2</sup></b></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFS1</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cystic leukoencephalopathy</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.b_nit.2001.1344">B&#x000e9;nit et al [2001]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFS2</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.loeffen.2001.195">Loeffen et al [2001]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFS3</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.b_nit.2004.14">B&#x000e9;nit et al [2004]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFS4</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.budde.2000.63">Budde et al [2000]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFS7</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.triepels.1999.787">Triepels et al [1999]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFS8</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Leukodystrophy</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.loeffen.1998.1598">Loeffen et al [1998]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFV1</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cystic leukoencephalopathy</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.b_nit.2001.1344">B&#x000e9;nit et al [2001]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFA2</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 family</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.hoefs.2008.1306">Hoefs et al [2008]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFA9</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 family</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.van_den_bosch.2012.10">van den Bosch et al [2012]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFA10</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 family</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.hoefs.2011.270">Hoefs et al [2011]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFA12</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 family</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe dystonia</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypertrichosis</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.ostergaard.2011.737">Ostergaard et al [2011]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFAF2</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MRI: symmetric lesions in mamillo-thalamic tracts, substantia nigra/medial lemniscus, medial longitudinal fasciculus, &#x00026; spinothalamic tracts</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.barghuti.2008.78">Barghuti et al [2008]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFAF5</i><br />(<i>C20orf7</i>)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">FILA (1 patient); survival into 20s in 1 family</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.sugiana.2008.468">Sugiana et al [2008]</a><br /><a class="bk_pop" href="#leigh-nucl-ov.REF.gerards.2010.507">Gerards et al [2010]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFAF6</i><br />(<i>C8orf38</i>)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 family</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.pagliarini.2008.112">Pagliarini et al [2008]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FOXRED1</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures &#x00026; myoclonus</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Slowly progressive; survival possible into 20s</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.calvo.2010.851">Calvo et al [2010]</a><br /><a class="bk_pop" href="#leigh-nucl-ov.REF.fassone.2010.4837">Fassone et al [2010]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" colspan="6" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Complex II-deficient Leigh syndrome&#x000a0;<sup>3</sup></b></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SDHA</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+ (may occur)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Course may be indolent w/survival into adulthood.</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.bourgeron.1995.144">Bourgeron et al [1995]</a><br /><a class="bk_pop" href="#leigh-nucl-ov.REF.pagnamenta.2006.214">Pagnamenta et al [2006]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SDHAF1</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Leukoencephalopathy on MRI (1 case neuropathologic LS)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.ohlenbusch.2012.69">Ohlenbusch et al [2012]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" colspan="6" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Complex III-deficient Leigh syndrome&#x000a0;<sup>4</sup></b></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>UQCRQ</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 family</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Slowly progressive; survival into 30s</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.barel.2008.1211">Barel et al [2008]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TTC19</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe olivo-ponto-cerebellar atrophy</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Slowly progressive; survival into 20s/30s</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.ghezzi.2011.259">Ghezzi et al [2011]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BCS1L</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SNHL</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proximal renal tubulopathy, hepatic involvement, pili torti</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.de_lonlay.2001.57">de Lonlay et al [2001]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" colspan="6" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Complex IV-deficient Leigh syndrome&#x000a0;<sup>5</sup></b></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFA4</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 family</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Epilepsy, sensory axonal peripheral neuropathy</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Slowly progressive; survival into 20s/30s</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.pitceathly.2013.1795">Pitceathly et al [2013]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SURF1</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~50% of complex IV deficient LS (~10% of all LS)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental regression (71%), nystagmus + ophthalmoplegia (52%), movement disorder (52%)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypertrichosis (48%); median survival 5.4 yrs</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.wedatilake.2013.96">Wedatilake et al [2013]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COX10</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SNHL</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anemia (due to defect of mitochondrial heme A biosynthesis)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.antonicka.2003.2693">Antonicka et al [2003]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COX15</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.oquendo.2004.540">Oquendo et al [2004]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCO2</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.joost.2010.227">Joost et al [2010]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LRPPRC</i>&#x000a0;<sup>6</sup></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Metabolic &#x00026; neurologic (stroke-like) crises</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Survival 5 days - 30 yrs; median age at death 1.6 yrs</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.debray.2011.183">Debray et al [2011]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TACO1</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 family</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive dysfunction, dystonia, visual impairment</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Late onset (4-16 yrs), slowly progressive</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.weraarpachai.2009.833">Weraarpachai et al [2009]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PET100</i>&#x000a0;<sup>7</sup></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Prominent seizures</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Survival to 20s (50%)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.lim.2014.209">Lim et al [2014]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">FILA = fatal infantile lactic acidosis; HCM = hypertrophic cardiomyopathy; LS = Leigh syndrome; SNHL = sensorineural hearing loss</p></div></dd><dt>1. </dt><dd><div id="leigh-nucl-ov.TF.1.1"><p class="no_margin">Neurologic findings other than those of classic Leigh syndrome</p></div></dd><dt>2. </dt><dd><div id="leigh-nucl-ov.TF.1.2"><p class="no_margin">Defining feature: complex I deficiency (identified on muscle biopsy)</p></div></dd><dt>3. </dt><dd><div id="leigh-nucl-ov.TF.1.3"><p class="no_margin">Complex II deficiency on muscle biopsy; also succinate peak on brain MRS</p></div></dd><dt>4. </dt><dd><div id="leigh-nucl-ov.TF.1.4"><p class="no_margin">Complex III deficiency on muscle biopsy</p></div></dd><dt>5. </dt><dd><div id="leigh-nucl-ov.TF.1.5"><p class="no_margin">Complex IV deficiency on muscle biopsy. Note: In <i>SURF1-</i>related LS, complex IV deficiency is more severe in cultured skin fibroblasts than muscle.</p></div></dd><dt>6. </dt><dd><div id="leigh-nucl-ov.TF.1.6"><p class="no_margin">Founder pathogenic allelic variant in French-Canadian population from Saguenay-Lac St Jean</p></div></dd><dt>7. </dt><dd><div id="leigh-nucl-ov.TF.1.7"><p class="no_margin">Founder <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in Lebanese population</p></div></dd></dl></div></div></div><div id="leigh-nucl-ov.T.autosomal_recessive_leig_1" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Autosomal Recessive Leigh-Like Syndromes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig_1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__leigh-nucl-ov.T.autosomal_recessive_leig_1_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" style="text-align:left;vertical-align:middle;">Disease Name</th><th id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Distinguishing Clinical Features</th><th id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="2" scope="col" colspan="1" headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" style="text-align:left;vertical-align:middle;">Laboratory Findings</th><th id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="2" scope="col" colspan="1" headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" style="text-align:left;vertical-align:middle;">Reference</th></tr><tr><th headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3" id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Neurologic</th><th headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3" id="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other</th></tr></thead><tbody><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrial DNA depletion syndrome (hepatocerebral)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpers/"><i>POLG</i></a></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Roving eye movements, prominent seizures</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hepatocerebral disease</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple RCE deficiencies&#x000a0;<sup>1</sup>, <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> complex IV defic (rare)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.taanman.2009.248">Taanman et al [2009]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrial DNA depletion syndrome (encephalopathic)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sucla2-def/"><i>SUCLA2</i></a>&#x000a0;<sup>2</sup></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypotonia, muscle atrophy, hyperkinesia, severe SNHL</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Growth retardation</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MMA, multiple RCE deficiencies</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.elpeleg.2005.1081">Elpeleg et al [2005]</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.ostergaard.2007.853">Ostergaard et al [2007]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/suclg1-mtddepl/"><i>SUCLG1</i></a></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe myopathy</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Recurrent hepatic failure</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MMA, multiple RCE deficiencies</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.van_hove.2010.159">Van Hove et al [2010]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fbxl4-mtddepl/"><i>FBXL4</i></a></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Facial dysmorphism, skeletal abnormalities, poor growth, gastrointestinal dysmotility, renal tubular acidosis</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Multiple RCE deficiencies</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.shamseldin.2012.234">Shamseldin et al [2012]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Defect of mt tRNA modification</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TRMU</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LS reported in 1 person</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Usually causes benign reversible liver failure w/out neurologic symptoms</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.taylor.2014.68">Taylor et al [2014]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrial translation (formylation) defect</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MTFMT</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cystic leukoencephalopathy in some</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May be slowly progressive in some, w/survival into 20s</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.tucker.2011.428">Tucker et al [2011]</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.haack.2014.342">Haack et al [2014]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fars2-def/">Phenylalanyl aminoacyl tRNA synthetase deficiency</a> (mt translation defect)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FARS2</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe epilepsy; Alpers neuropathology in others</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Isolated complex IV deficiency in 1 person; enzymology not performed in any others</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.shamseldin.2012.234">Shamseldin et al [2012]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Glutamyl aminoacyl tRNA synthetase deficiency (mt translation defect)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EARS2</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Leukoencephalopathy w/thalamus &#x00026; brain stem involvement &#x00026; &#x02191; lactate (MRI)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Improvement can occur, liver failure in some cases</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple RCE deficiencies</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.martinelli.2012.383">Martinelli et al [2012]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Isoleucyl aminoacyl tRNA synthetase deficiency (mt translation defect)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IARS2</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LS causing death at 18m in 1 child; SNHL, peripheral sensory neuropathy</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cataracts, growth hormone deficiency, skeletal dysplasia in 3 adults</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Enzymology not performed</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.schwartzentruber.2014.1285">Schwartzentruber et al [2014]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrial translation (elongation) defect</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GFM1</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Axial hypotonia, spasticity, refractory seizures</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive hepato-encephalopathy in some</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Multiple RCE deficiencies</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.valente.2007.44">Valente et al [2007]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>TSFM</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Juvenile-onset, ataxia, neuropathy, optic atrophy</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Growth retardation, HCM</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.ahola.2014.743">Ahola et al [2014]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrial translation defect</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>C12orf65</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmoplegia, optic atrophy, axonal neuropathy</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Relatively slow disease progression</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple RCE deficiencies (fbs)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.antonicka.2010.115">Antonicka et al [2010]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Polyribonucleotide nucleotidyltransferase deficiency</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PNPT1</i>&#x000a0;<sup>3</sup></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Choreoathetosis &#x00026; dyskinesia; also <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> SNHL</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe hypotonia</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complex III+IV deficiency in liver in 1 person (normal activity in mb &#x00026; fbs)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.vedrenne.2012.912">Vedrenne et al [2012]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Coenzyme Q<sub>10</sub> deficiency (decaprenyl-diphosphate synthase subunit 2 deficiency)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PDSS2</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refractory seizures</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nephrotic syndrome&#x000a0;<sup>4</sup></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complexes I+III, II+III &#x00026; coenzyme Q<sub>10</sub> deficiency (mb)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.l_pez.2006.1125">L&#x000f3;pez et al [2006]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Lipoic acid synthesis defect</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LIAS</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures w/burst suppression (EEG)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild HCM</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Combined deficiency of PDH + glycine cleavage enzyme, &#x02191; urine &#x00026; plasma glycine, defic lipoylated proteins (western blot)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.baker.2014.366">Baker et al [2014]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>LIPT1</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 person w/LS; 2 w/FILA</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Liver dysfunction</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; glutamine &#x00026; proline, &#x02193; levels of lysine &#x00026; branched-chain amino acids &#x00026; <i>normal</i> glycine (unlike other lipoic acid synthesis defects); severe &#x02193; of PDH &#x00026; &#x003b1;-KGDH activity &#x00026; strongly &#x02193; BCKDH activ (fbs); nml RCE activ</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.soreze.2013.192">Soreze et al [2013]</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.tort.2014.1907">Tort et al [2014]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/megdel/">MEGDEL syndrome</a></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SERAC1</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SNHL</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May have liver involvement in infancy; later normalizes</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3-methylglutaconic aciduria</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.wortmann.2012.797">Wortmann et al [2012]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PDH B defiency</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PDHB</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CC agenesis/hypoplasia</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PDH deficiency (fbs)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.quintana.2009.s339">Quintana et al [2009]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dld-def/">Dihydrolipoamide dehydrogenase defic</a></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DLD</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Episodic encephalopathy</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypoglycemia, ketoacidosis, liver failure</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; plasma branched-chain amino acids, PDH deficiency (fbs)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.grafakou.2003.714">Grafakou et al [2003]</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.quinonez.2013.67">Quinonez et al [2013]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PDH E3 binding protein deficiency</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PDHX</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Thin CC/CC agenesis; status epilepticus late in disease (teens/20s)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PDH deficiency (fbs)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.schiff.2006.709">Schiff et al [2006]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Thiamine metabolism dysfunction syndrome 4 (bilateral striatal degeneration &#x00026; progressive polyneuropathy type)&#x000a0;<sup>5</sup></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC25A19</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bilateral striatal necrosis; episodic encephalopathy; chronic progressive polyneuropathy resulting in distal weakness &#x00026; contractures</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Enzymology not performed</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.spiegel.2009.419">Spiegel et al [2009]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TPK1</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Episodic encephalopathy, ataxia, dystonia, spasticity</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-ketoglutaric aciduria</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.mayr.2011.806">Mayr et al [2011]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/biotin/">Biotinidase deficiency</a></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BTD</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deafness, optic atrophy, seizures, ataxia&#x000a0;<sup>4</sup></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Alopecia, eczema</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Characteristic organic aciduria</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.mitchell.1986.129">Mitchell et al [1986]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bgd-biotin/">Biotin-thiamine-responsive basal ganglia disease</a> (thiamine transporter-2 deficiency)</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC19A3</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 4</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nml RCE activity</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.gerards.2013.882">Gerards et al [2013]</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.fassone.2013.200838">Fassone et al [2013]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ee/">Ethylmalonic encephalopathy</a></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ETHE1</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurodevelopmental delay &#x00026; regression, pyramidal &#x00026; extrapyramidal signs</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Acrocyanosis, petechiae &#x00026; diarrhea in infancy</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ethylmalonic aciduria</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.mineri.2008.473">Mineri et al [2008]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3-hydroxyisobutyrylCoA hydrolase deficiency</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HIBCH</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental regression, seizures, ataxia</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; plasma 4-hydroxybutyrylcarnitine levels; variable deficiency of RCEs &#x00026; PDH</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.ferdinandusse.2013.188">Ferdinandusse et al [2013]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/echs1-def/">Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency</a></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ECHS1</i></td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Psychomotor delay, SNHL, nystagmus, hypotonia, spasticity, athetoid mvmts</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_3 hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">HCM</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; urinary excretion of S-(2-carboxypropyl) cysteine; normal RCE activity in 1 person, mult RCE deficiency in 1 other</td><td headers="hd_h_leigh-nucl-ov.T.autosomal_recessive_leig_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.peters.2014.2903">Peters et al [2014]</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.sakai.2015.232">Sakai et al [2015]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">&#x003b1;-KGDH = alpha-ketoglutarate dehydrogenase; BCKDH = branched chain ketoacid dehydrogenase; CC = corpus callosum; EEG = electroencephalogram; fbs = cultured skin fibroblasts; FILA = fatal infantile lactic acidosis; HCM = hypertrophic cardiomyopathy; LS = Leigh syndrome; mb = muscle biopsy; MDDS = mitochondrial DNA depletion syndrome; MMA = methylmalonic aciduria; MRS = magnetic resonance spectroscopy; mt = mitochondrial; PDH = pyruvate dehydrogenase; RCE = respiratory chain enzyme; SNHL = sensorineural hearing loss</p></div></dd><dt>1. </dt><dd><div id="leigh-nucl-ov.TF.2.1"><p class="no_margin">RCE activity measured on muscle biopsy except in one case noted</p></div></dd><dt>2. </dt><dd><div id="leigh-nucl-ov.TF.2.2"><p class="no_margin">Founder variant in Faroe Islands</p></div></dd><dt>3. </dt><dd><div id="leigh-nucl-ov.TF.2.3"><p class="no_margin">Single family reported</p></div></dd><dt>4. </dt><dd><div id="leigh-nucl-ov.TF.2.4"><p class="no_margin">Treatable; see <a href="#leigh-nucl-ov.Management">Management</a>.</p></div></dd><dt>5. </dt><dd><div id="leigh-nucl-ov.TF.2.5"><p class="no_margin">Allelic with <a href="/books/n/gene/amish-mcph/">Amish lethal microcephaly</a>, mitochondrial thiamine pyrophosphate <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> deficiency</p></div></dd></dl></div></div></div></div><div id="leigh-nucl-ov.XLinked_Leigh_Syndrome_and"><h3>X-Linked Leigh Syndrome and Leigh-Like Syndromes</h3><p>Nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome and Leigh-like syndrome inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner are summarized in <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.xlinked_leigh_syndrome_a/?report=objectonly" target="object" rid-figpopup="figleighnuclovTxlinkedleighsyndromea" rid-ob="figobleighnuclovTxlinkedleighsyndromea">Table 3</a>.</p><div id="leigh-nucl-ov.T.xlinked_leigh_syndrome_a" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>X-Linked Leigh Syndrome and Leigh-Like Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK320989/table/leigh-nucl-ov.T.xlinked_leigh_syndrome_a/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__leigh-nucl-ov.T.xlinked_leigh_syndrome_a_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disease Name</th><th id="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing Features</th><th id="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Laboratory Findings</th><th id="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th></tr></thead><tbody><tr><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PDH deficiency</td><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PDHA1</i></td><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Psychomotor retardation; seizures; choreoathetosis; dystonia; episodic ataxia in some; microcephaly; cerebral atrophy; cystic lesions in basal ganglia, brain stem, &#x00026; cerebral hemispheres; agenesis of corpus callosum; facial dysmorphism</td><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low/low-normal lactate/pyruvate ratio in blood and CSF; PDH deficiency (fbs)</td><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.rahman.1996.343">Rahman et al [1996]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complex I-deficient LS</td><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFA1</i></td><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental delay; axial hypotonia; nystagmus; choreoathetosis; myoclonic epilepsy; survival to 30s in 2 cases</td><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complex I deficiency (mb)</td><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.fernandezmoreira.2007.73">Fernandez-Moreira et al [2007]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> mt encephalomyopathy</td><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AIFM1</i></td><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Encephalomyopathy w/bilateral striatal lesions</td><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Multiple RCE deficiencies (mb)</td><td headers="hd_h_leigh-nucl-ov.T.xlinked_leigh_syndrome_a_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.ghezzi.2010.639">Ghezzi et al [2010]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">LS = Leigh syndrome; PDH = pyruvate dehydrogenase; RCE = respiratory chain enzyme</p></div></dd></dl></div></div></div></div><div id="leigh-nucl-ov.Differential_Diagnosis_of"><h3>Differential Diagnosis of Nuclear Gene-Encoded Leigh Syndrome</h3><p>Differential diagnosis of nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome includes mitochondrial DNA-associated Leigh syndrome, non-mitochondrial genetic causes of bilateral striatal necrosis (e.g., mutation of <i>ADAR1</i>, <i>NUP62</i>, or <i>RANBP2</i>), and acquired non-genetic causes such as viral encephalopathy.</p><p>Mitochondrial DNA-associated Leigh syndrome (also known as maternally inherited Leigh syndrome, MILS) is summarized in <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.mitochondrial_dnaassocia/?report=objectonly" target="object" rid-figpopup="figleighnuclovTmitochondrialdnaassocia" rid-ob="figobleighnuclovTmitochondrialdnaassocia">Table 4</a>. See also <a href="/books/n/gene/narp/">Mitochondrial DNA-Associated Leigh Syndrome and NARP</a> and <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>.</p><div id="leigh-nucl-ov.T.mitochondrial_dnaassocia" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Mitochondrial DNA-Associated Leigh syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK320989/table/leigh-nucl-ov.T.mitochondrial_dnaassocia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__leigh-nucl-ov.T.mitochondrial_dnaassocia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Muscle Biopsy Findings</th><th id="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th></tr></thead><tbody><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-ND1</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_2" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;">Complex I deficiency</td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.kirby.2004.784">Kirby et al [2004]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-ND2</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.ugalde.2007.10">Ugalde et al [2007]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-ND3</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.lebon.2003.896">Lebon et al [2003]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-ND4</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.komaki.2003.293">Komaki et al [2003]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-ND5</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.santorelli.1997a.326">Santorelli et al [1997a]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-ND6</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.kirby.2000.102">Kirby et al [2000]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-CO3</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complex IV deficiency</td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.tiranti.2000.2733">Tiranti et al [2000]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-ATP6</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complex V deficiency</td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.harding.1992.629">Harding et al [1992]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TI</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_2" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;">Multiple RCE deficiencies</td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.cox.2012.258">Cox et al [2012]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TK</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.rahman.1996.343">Rahman et al [1996]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TL1</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.rahman.1996.343">Rahman et al [1996]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TV</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.mcfarland.2002.145">McFarland et al [2002]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TW</i></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.santorelli.1997b.256">Santorelli et al [1997b]</a></td></tr><tr><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Large-scale mtDNA <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a></td><td headers="hd_h_leigh-nucl-ov.T.mitochondrial_dnaassocia_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#leigh-nucl-ov.REF.rahman.1996.343">Rahman et al [1996]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">RCE = respiratory chain enzyme</p></div></dd></dl></div></div></div></div></div><div id="leigh-nucl-ov.Evaluation_Strategy"><h2 id="_leigh-nucl-ov_Evaluation_Strategy_">Evaluation Strategy</h2><p>Once Leigh syndrome or a Leigh-like syndrome (<a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig" rid-ob="figobleighnuclovTautosomalrecessiveleig">Table 1</a>, <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig_1/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig1" rid-ob="figobleighnuclovTautosomalrecessiveleig1">Table 2</a>, and <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.xlinked_leigh_syndrome_a/?report=objectonly" target="object" rid-figpopup="figleighnuclovTxlinkedleighsyndromea" rid-ob="figobleighnuclovTxlinkedleighsyndromea">Table 3</a>) is considered in an individual, determining the specific cause aids in discussions of prognosis and treatment (see <a href="#leigh-nucl-ov.Testing">Testing</a>, <b>Treatable disorders</b>) and in <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>. The following information can be used to establish the specific cause of Leigh syndrome for a given individual: clinical findings, family history, specialized testing, and molecular genetic/<a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing.</p><p><b>Clinical findings.</b> Clinical manifestations of Leigh syndrome and Leigh-like syndrome are described in <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig" rid-ob="figobleighnuclovTautosomalrecessiveleig">Table 1</a>, <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig_1/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig1" rid-ob="figobleighnuclovTautosomalrecessiveleig1">Table 2</a>, and <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.xlinked_leigh_syndrome_a/?report=objectonly" target="object" rid-figpopup="figleighnuclovTxlinkedleighsyndromea" rid-ob="figobleighnuclovTxlinkedleighsyndromea">Table 3</a>.</p><p>Although retrospective review of the more common genetic causes of Leigh syndrome (<a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig" rid-ob="figobleighnuclovTautosomalrecessiveleig">Table 1</a> and <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.xlinked_leigh_syndrome_a/?report=objectonly" target="object" rid-figpopup="figleighnuclovTxlinkedleighsyndromea" rid-ob="figobleighnuclovTxlinkedleighsyndromea">Table 3</a>) suggests some differences in <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, clinical findings in individuals with mutation of different genes typically overlap; thus, in only a few situations can specific clinical and/or imaging findings guide testing of a subset of genes. For example:</p><ul><li class="half_rhythm"><div>More than 40 individuals with pathogenic variants in <i>SURF1</i> or <i>LRPPRC</i> have been reported [<a class="bk_pop" href="#leigh-nucl-ov.REF.debray.2011.183">Debray et al 2011</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.wedatilake.2013.96">Wedatilake et al 2013</a>]. Mean survival is longer in those with SURF1 deficiency (5.4 years) than in those with LRPPRC deficiency (1.8 years), apparently due to the occurrence of more frequent and severe metabolic crises in the latter. SURF1 deficiency also appears to have a high incidence of hypertrichosis and peripheral neuropathy [<a class="bk_pop" href="#leigh-nucl-ov.REF.wedatilake.2013.96">Wedatilake et al 2013</a>].</div></li><li class="half_rhythm"><div>Brain malformations are typically seen in those with mutation of <i>PDHA1</i> [<a class="bk_pop" href="#leigh-nucl-ov.REF.patel.2012.385">Patel et al 2012</a>]. Specific brain tracts may be involved in some subgroups of complex I deficiency; for example, brain stem lesions are seen within the mamillothalamic tracts, substantia nigra, medial lemniscus, medial longitudinal fasciculus, and spinothalamic tracts on T<sub>2</sub>-weighted MRI in individuals with mutation of <i>NDUFAF2</i> [<a class="bk_pop" href="#leigh-nucl-ov.REF.fassone.2012.578">Fassone &#x00026; Rahman 2012</a>].</div></li></ul><p><b>Family history.</b> A three-generation family history should be obtained with attention to other relatives with neurologic signs and symptoms, or other clinical features compatible with mitochondrial disease. Documentation of relevant findings in relatives can be accomplished either through direct examination of those individuals or review of their medical records including the results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, neuroimaging studies, and autopsy examinations.</p><p>Specific findings such as a maternal family history of disease may prompt initial investigation of mitochondrial DNA, or <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> may prompt initial investigation of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> genes. Of course, such features are sometimes a chance occurrence and should be followed up with more comprehensive testing if no pathogenic variants are identified [<a class="bk_pop" href="#leigh-nucl-ov.REF.alston.2011.1226">Alston et al 2011</a>].</p><div id="leigh-nucl-ov.Testing"><h3>Testing</h3><p><b>Elevated lactate levels in blood and/or cerebrospinal fluid</b> can:</p><ul><li class="half_rhythm"><div>Suggest Leigh syndrome versus other disorders with similar clinical findings;</div></li><li class="half_rhythm"><div>Implicate mutation of one of the genes causing PDH deficiency when the ratio of lactate to pyruvate is normal to low [<a class="bk_pop" href="#leigh-nucl-ov.REF.debray.2007.916">Debray et al 2007</a>].</div></li></ul><p><b>Measurement of enzyme activity.</b> Enzymes, such as PDH, are typically measured in cultured skin fibroblasts (fbs in <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig" rid-ob="figobleighnuclovTautosomalrecessiveleig">Table 1</a>, <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig_1/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig1" rid-ob="figobleighnuclovTautosomalrecessiveleig1">Table 2</a>, and <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.xlinked_leigh_syndrome_a/?report=objectonly" target="object" rid-figpopup="figleighnuclovTxlinkedleighsyndromea" rid-ob="figobleighnuclovTxlinkedleighsyndromea">Table 3</a>), and respiratory chain enzymes are typically measured in skeletal muscle (mb in <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig" rid-ob="figobleighnuclovTautosomalrecessiveleig">Table 1</a>, <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig_1/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig1" rid-ob="figobleighnuclovTautosomalrecessiveleig1">Table 2</a>, and <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.xlinked_leigh_syndrome_a/?report=objectonly" target="object" rid-figpopup="figleighnuclovTxlinkedleighsyndromea" rid-ob="figobleighnuclovTxlinkedleighsyndromea">Table 3</a>). Although identifying an enzyme defect can help prioritize <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, this approach can still leave a large number of genes to be tested (e.g., respiratory chain complex I-deficient Leigh syndrome has to date been shown to be caused by pathogenic variants in at least 15 <a class="def" href="/books/n/gene/glossary/def-item/autosomal/">autosomal</a> genes (<a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig" rid-ob="figobleighnuclovTautosomalrecessiveleig">Table 1</a>), one <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (<a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.xlinked_leigh_syndrome_a/?report=objectonly" target="object" rid-figpopup="figleighnuclovTxlinkedleighsyndromea" rid-ob="figobleighnuclovTxlinkedleighsyndromea">Table 3</a>), and six genes encoded by mtDNA (<a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.mitochondrial_dnaassocia/?report=objectonly" target="object" rid-figpopup="figleighnuclovTmitochondrialdnaassocia" rid-ob="figobleighnuclovTmitochondrialdnaassocia">Table 4</a>).</p><p><b>Molecular genetic testing</b> approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> can be considered if (1) mutation of a particular gene accounts for a large proportion of the disease <b>or</b> (2) clinical findings, laboratory findings, and/or ancestry (<a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig" rid-ob="figobleighnuclovTautosomalrecessiveleig">Table 1</a>, <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.autosomal_recessive_leig_1/?report=objectonly" target="object" rid-figpopup="figleighnuclovTautosomalrecessiveleig1" rid-ob="figobleighnuclovTautosomalrecessiveleig1">Table 2</a>, and <a class="figpopup" href="/books/NBK320989/table/leigh-nucl-ov.T.xlinked_leigh_syndrome_a/?report=objectonly" target="object" rid-figpopup="figleighnuclovTxlinkedleighsyndromea" rid-ob="figobleighnuclovTxlinkedleighsyndromea">Table 3</a>) indicate that mutation of a particular gene is most likely. Typically <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the gene of interest is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> for <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders or no pathogenic variant for either autosomal recessive or <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorders is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes many or all of these genes and other genes of interest (see <a href="#leigh-nucl-ov.Differential_Diagnosis_of">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, and mitochondrial sequencing may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) fails to confirm a diagnosis in an individual with features of nuclear gene-encoded Leigh syndrome. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><p><b>Treatable disorders.</b> The causes of nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh-like syndrome that are treatable (see <a href="#leigh-nucl-ov.Treatment_of_Manifestation">Treatment of Manifestations</a>) include:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/bgd-biotin/">Biotin-thiamine-responsive basal ganglia disease</a> (BTBGD) (also known as thiamine transporter-2 deficiency) (mutation of <i>SLC19A3</i>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/biotin/">Biotinidase deficiency</a> (<i>BTD</i>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/coq10-def/">Coenzyme Q<sub>10</sub> biosynthesis defect</a> (<i>PDSS2</i>)</div></li></ul><p>These disorders should be rapidly tested biochemically or genetically as indicated or, if this is not possible, trials of the relevant vitamins/cofactors should be instituted as soon as the diagnosis is considered. Ideally, therapy should continue until these disorders have been excluded by biochemical and/or genetic testing, and continued for life if the diagnosis is confirmed.</p></div></div><div id="leigh-nucl-ov.Genetic_Counseling"><h2 id="_leigh-nucl-ov_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="leigh-nucl-ov.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome and Leigh-like syndrome are inherited in either an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> or <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="leigh-nucl-ov.Autosomal_Recessive_Leigh_1"><h3>Autosomal Recessive Leigh Syndrome</h3><div id="leigh-nucl-ov.Risk_to_Family_Members"><h4>Risk to Family Members</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> No <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has reproduced.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="leigh-nucl-ov.Carrier_Heterozygote_Detec"><h4>Carrier (Heterozygote) Detection</h4><p>Carrier testing for at-risk relatives requires prior identification of the pathogenic variants in the family.</p></div></div><div id="leigh-nucl-ov.XLinked_Leigh_Syndrome"><h3>X-Linked Leigh Syndrome</h3><div id="leigh-nucl-ov.Risk_to_Family_Members_1"><h4>Risk to Family Members</h4><p>Nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome caused by mutation of <i>PDHA1</i>, <i>NDUFA1,</i> and <i>AIFM1</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p><p>Almost equal numbers of males and females <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with <i>PDHA1</i>-associated Leigh syndrome have been reported [<a class="bk_pop" href="#leigh-nucl-ov.REF.lissens.2000.209">Lissens et al 2000</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.imbard.2011.507">Imbard et al 2011</a>]. Although relatively few affected individuals with <i>NDUFA1</i>-associated LS and <i>AIFM1-</i>associated LS have been reported, it is expected that the same gender ratio would be seen in all three disorders.</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child will not have <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Leigh syndrome nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>PDHA1</i>, <i>NDUFA1,</i> or <i>AIFM1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>The mother of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child may be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; see <a href="#leigh-nucl-ov.Heterozygote_Carrier_Detec">Heterozygote (Carrier) Detection</a>. Approximately 25% of mothers of children with <i>PDHA1</i> pathogenic variants were found to be heterozygous for a <i>PDHA1</i> variant [<a class="bk_pop" href="#leigh-nucl-ov.REF.lissens.2000.209">Lissens et al 2000</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.imbard.2011.507">Imbard et al 2011</a>].</div></li><li class="half_rhythm"><div>If only one family member is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> or the affected child may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> or somatic <i>PDHA1</i>, <i>NDUFA1,</i> or <i>AIFM1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (in which case the mother is not <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>).</div><ul><li class="half_rhythm"><div>Data reported by <a class="bk_pop" href="#leigh-nucl-ov.REF.lissens.2000.209">Lissens et al [2000]</a> and <a class="bk_pop" href="#leigh-nucl-ov.REF.imbard.2011.507">Imbard et al [2011]</a> suggest that up to 75% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>In at least seven <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> has been demonstrated with mutation presumably occurring in early or mid-embryogenesis [<a class="bk_pop" href="#leigh-nucl-ov.REF.imbard.2011.507">Imbard et al 2011</a>].</div></li></ul></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected child is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a>. Note: If a woman has more than one affected child and no other affected relatives and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>Note: If the mother is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, she may have somatic and <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs depends on the genetic status of the mother.</div></li><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <i>PDHA1</i>, <i>NDUFA1</i>, or <i>AIFM1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant are likely to be affected unless they have a favorably skewed <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> ratio.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>PDHA1</i>, <i>NDUFA1</i>, or <i>AIFM1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is low but greater than that of the general population because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> No <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has reproduced.</p><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts may be at risk of being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and the aunts' sons may be at risk of inheriting a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p></div><div id="leigh-nucl-ov.Heterozygote_Carrier_Detec"><h4>Heterozygote (Carrier) Detection</h4><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p>Females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>PDHA1</i>, <i>NDUFA1</i>, or <i>AIFM1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are likely to be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> unless they have a favorably skewed <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> ratio. The pattern of X-chromosome inactivation, particularly in the brain, is expected to largely determine clinical status.</p><p>Note: The 11 <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> mothers reported by <a class="bk_pop" href="#leigh-nucl-ov.REF.imbard.2011.507">Imbard et al [2011]</a> were said to be asymptomatic. In the authors' experience, however, some learning difficulties or other features are often present.</p></div></div><div id="leigh-nucl-ov.Related_Genetic_Counseling"><h3>Related Genetic Counseling Issues</h3><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="leigh-nucl-ov.Prenatal_Testing_and_Preim"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome are possible.</p><p>Note: For families with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Leigh syndrome, molecular genetic prenatal test results cannot be used to predict the risk of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> outcome for a female conceptus carrying the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div></div><div id="leigh-nucl-ov.Resources"><h2 id="_leigh-nucl-ov_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/leigh-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Leigh syndrome</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li><li class="half_rhythm"><div><b>Mito Foundation (formerly the Australian Mitochondrial Disease Foundation)</b></div><div>21 Mary Street</div><div>Suite 3</div><div>Surry Hills New South Wales 2010</div><div>Australia</div><div><b>Phone:</b> 61-1-300-977-180</div><div><b>Fax:</b> 61-2-9999-3474</div><div><b>Email:</b> info@mito.org.au</div><div><a href="https://www.mito.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mito.org.au</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>The Lily Foundation</b></div><div>31 Warren Park</div><div>Surrey CR6 9LD</div><div>United Kingdom</div><div><b>Phone:</b> 07947 257247</div><div><b>Fax:</b> 01883 623799</div><div><b>Email:</b> liz@thelilyfoundation.org.uk</div><div><a href="http://www.thelilyfoundation.org.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.thelilyfoundation.org.uk</a></div></li><li class="half_rhythm"><div><b>United Mitochondrial Disease Foundation (UMDF)</b></div><div>8085 Saltsburg Road</div><div>Suite 201</div><div>Pittsburg PA 15239</div><div><b>Phone:</b> 888-317-8633 (toll-free); 412-793-8077</div><div><b>Fax:</b> 412-793-6477</div><div><b>Email:</b> info@umdf.org</div><div><a href="http://www.umdf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.umdf.org</a></div></li><li class="half_rhythm"><div><b>Mitochondrial Disease Registry and Tissue Bank</b></div><div>Massachusetts General Hospital</div><div>185 Cambridge Street</div><div>Simches Research Building 5-238</div><div>Boston MA 02114</div><div><b>Phone:</b> 617-726-5718</div><div><b>Fax:</b> 617-724-9620</div><div><b>Email:</b> nslate@partners.org</div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: North American Mitochondrial Disease Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/namdc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Contact Registry</a></div></li></ul></div><div id="leigh-nucl-ov.Management"><h2 id="_leigh-nucl-ov_Management_">Management</h2><div id="leigh-nucl-ov.Treatment_of_Manifestation"><h3>Treatment of Manifestations</h3><p><b>Specific treatment</b> is possible for the following three nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh-like syndromes:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/bgd-biotin/"><b>Biotin-thiamine-responsive basal ganglia disease</b></a>
<b>(BTBGD)</b> (also known as thiamine transporter-2 deficiency) (mutation of <i>SLC19A3</i>). Biotin (5-10 mg/kg/day) and thiamine (in doses ranging from 300-900 mg) should be given orally as early in the disease course as possible and continued lifelong. Symptoms typically resolve within days.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/biotin/"><b>Biotinidase deficiency</b></a>
<b>(<i>BTD</i>).</b> All symptomatic children with profound biotinidase deficiency improve when treated with 5-10 mg of oral biotin per day. Biotin treatment should be continued lifelong in all individuals with profound biotinidase deficiency.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/coq10-def/"><b>Coenzyme Q<sub>10</sub> biosynthesis deficiency</b></a>
<b>(<i>PDSS2</i>).</b> Supplementation with oral coenzyme Q<sub>10</sub> (10-30 mg/kg/day in children and 1200-3000 mg/day in adults) should be commenced as early in the disease course as possible and continued lifelong [<a class="bk_pop" href="#leigh-nucl-ov.REF.rahman.2012.76">Rahman et al 2012</a>]</div></li></ul><p><b>Supportive management</b> for any of the causes of nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome includes the following:</p><ul><li class="half_rhythm"><div><b>Acidosis.</b> Sodium bicarbonate or sodium citrate is appropriate for acute exacerbations of acidosis.</div></li><li class="half_rhythm"><div><b>Seizures.</b> Appropriate antiepileptic drugs tailored to the type of seizure should be administered under the supervision of a neurologist. Sodium valproate and barbiturates should be avoided because of their inhibitory effects on the mitochondrial respiratory chain [<a class="bk_pop" href="#leigh-nucl-ov.REF.melegh.1997.257">Melegh &#x00026; Trombitas 1997</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.anderson.2002.9203">Anderson et al 2002</a>].</div></li><li class="half_rhythm"><div><b>Dystonia</b></div><ul><li class="half_rhythm"><div>Benzhexol, baclofen, tetrabenezine, and gabapentin may be useful, alone or in various combinations; an initial low dose should be started and gradually increased until symptom control is achieved or intolerable side effects occur.</div></li><li class="half_rhythm"><div>Botulinum toxin injection has also been used in individuals with Leigh syndrome and severe intractable dystonia.</div></li></ul></li><li class="half_rhythm"><div><b>Cardiomyopathy.</b> Medical therapy may be required and should be supervised by a cardiologist.</div></li><li class="half_rhythm"><div><b>Nutrition.</b> Regular assessment of daily caloric intake and adequacy of dietary structure including micronutrients and feeding management is indicated.</div></li><li class="half_rhythm"><div><b>Psychological support</b> for the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual and family is essential.</div></li></ul></div><div id="leigh-nucl-ov.Prevention_of_Primary_Mani"><h3>Prevention of Primary Manifestations</h3><p>For treatment of the following disorders, see <a href="#leigh-nucl-ov.Treatment_of_Manifestation">Treatment of Manifestations</a>.</p><ul><li class="half_rhythm"><div>Thiamine transporter deficiency (mutation of <i>SLC19A3</i>)</div></li><li class="half_rhythm"><div>Biotinidase deficiency (<i>BTD</i>)</div></li><li class="half_rhythm"><div>Coenzyme Q<sub>10</sub> biosynthesis defect (<i>PDSS2</i>)</div></li></ul></div><div id="leigh-nucl-ov.Prevention_of_Secondary_Co"><h3>Prevention of Secondary Complications</h3><p><b>Anesthesia</b> can potentially aggravate respiratory symptoms and precipitate respiratory failure; thus, careful consideration should be given to its use and to monitoring the individual prior to, during, and after its use [<a class="bk_pop" href="#leigh-nucl-ov.REF.shear.2004.792">Shear &#x00026; Tobias 2004</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.niezgoda.2013.785">Niezgoda &#x00026; Morgan 2013</a>].</p></div><div id="leigh-nucl-ov.Surveillance"><h3>Surveillance</h3><p>Affected individuals should be followed at regular intervals (typically every 6-12 months) to monitor progression and the appearance of new manifestations. Neurologic, ophthalmologic, audiologic, and cardiologic evaluations are recommended.</p></div><div id="leigh-nucl-ov.AgentsCircumstances_to_Avo"><h3>Agents/Circumstances to Avoid</h3><p><b>Sodium valproate and barbiturates</b> should be avoided because of their inhibitory effect on the mitochondrial respiratory chain [<a class="bk_pop" href="#leigh-nucl-ov.REF.melegh.1997.257">Melegh &#x00026; Trombitas 1997</a>, <a class="bk_pop" href="#leigh-nucl-ov.REF.anderson.2002.9203">Anderson et al 2002</a>].</p><p><b>Dichloroacetate (DCA)</b> reduces blood lactate by activating the PDH complex.</p><ul><li class="half_rhythm"><div>A double-blind, placebo-controlled trial of DCA in a different mitochondrial disease, <a href="/books/n/gene/melas/">MELAS</a>, found no benefit and in fact documented a toxic effect of DCA on peripheral nerves [<a class="bk_pop" href="#leigh-nucl-ov.REF.kaufmann.2006.324">Kaufmann et al 2006</a>].</div></li><li class="half_rhythm"><div>A subsequent report described the results of long-term administration of DCA to 36 children with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> lactic acidosis (randomized control trial followed by an open label extension) [<a class="bk_pop" href="#leigh-nucl-ov.REF.stacpoole.2008.e1223">Stacpoole et al 2008</a>]. This study concluded that oral DCA is well tolerated in young children with congenital lactic acidosis and that it was not possible to determine whether the peripheral neuropathy associated with long-term DCA administration is attributable to the drug or to the underlying disease process. It therefore appears prudent for individuals with nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-encoded Leigh syndrome to avoid DCA, in view of the underlying risk for peripheral neuropathy caused by the disease itself in these conditions.</div></li></ul></div></div><div id="leigh-nucl-ov.References"><h2 id="_leigh-nucl-ov_References_">References</h2><div id="leigh-nucl-ov.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.ahola.2014.743">Ahola S, Isohanni P, Euro L, Brilhante V, Palotie A, Pihko H, L&#x000f6;nnqvist T, Lehtonen T, Laine J, Tyynismaa H, Suomalainen A. Mitochondrial EFTs defects in juvenile-onset Leigh disease, ataxia, neuropathy, and optic atrophy. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">83</span>:743–51.</span> [<a href="/pmc/articles/PMC4150129/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4150129</span></a>] [<a href="/pubmed/25037205" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25037205</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.alston.2011.1226">Alston CL, He L, Morris AA, Hughes I, de Goede C, Turnbull DM, McFarland R, Taylor RW. Maternally inherited mitochondrial DNA disease in consanguineous families. <span><span class="ref-journal">Eur J Hum Genet. </span>2011;<span class="ref-vol">19</span>:1226–9.</span> [<a href="/pmc/articles/PMC3230363/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3230363</span></a>] [<a href="/pubmed/21712854" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21712854</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.anderson.2002.9203">Anderson CM, Norquist BA, Vesce S, Nicholls DG, Soine WH, Duan S, Swanson RA. Barbiturates induce mitochondrial depolarization and potentiate excitotoxic neuronal death. <span><span class="ref-journal">J Neurosci. </span>2002;<span class="ref-vol">22</span>:9203–9.</span> [<a href="/pmc/articles/PMC6758030/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6758030</span></a>] [<a href="/pubmed/12417645" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12417645</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.antonicka.2003.2693">Antonicka H, Leary SC, Guercin GH, Agar JN, Horvath R, Kennaway NG, Harding CO, Jaksch M, Shoubridge EA. Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early onset clinical phenotypes associated with isolated COX deficiency. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>:2693–702.</span> [<a href="/pubmed/12928484" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12928484</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.antonicka.2010.115">Antonicka H, Ostergaard E, Sasarman F, Weraarpachai W, Wibrand F, Pedersen AM, Rodenburg RJ, van der Knaap MS, Smeitink JA, Chrzanowska-Lightowlers ZM, Shoubridge EA. Mutations in C12orf65 in patients with encephalomyopathy and a mitochondrial translation defect. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">87</span>:115–22.</span> [<a href="/pmc/articles/PMC2896764/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2896764</span></a>] [<a href="/pubmed/20598281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20598281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.baker.2014.366">Baker PR 2nd, Friederich MW, Swanson MA, Shaikh T, Bhattacharya K, Scharer GH, Aicher J, Creadon-Swindell G, Geiger E, Maclean KN, Lee WT, Deshpande C, Freckmann ML, Shih LY, Wasserstein M, Rasmussen MB, Lund AM, Procopis P, Cameron JM, Robinson BH, Brown GK, Brown RM, Compton AG, Dieckmann CL, Collard R, Coughlin CR 2nd, Spector E, Wempe MF, Van Hove JL. Variant nonketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5. <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:366–79.</span> [<a href="/pmc/articles/PMC3914472/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3914472</span></a>] [<a href="/pubmed/24334290" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24334290</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.barel.2008.1211">Barel O, Shorer Z, Flusser H, Ofir R, Narkis G, Finer G, Shalev H, Nasasra A, Saada A, Birk OS. Mitochondrial complex III deficiency associated with a homozygous mutation in UQCRQ. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">82</span>:1211–6.</span> [<a href="/pmc/articles/PMC2427202/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2427202</span></a>] [<a href="/pubmed/18439546" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18439546</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.barghuti.2008.78">Barghuti F, Elian K, Gomori JM, Shaag A, Edvardson S, Saada A, Elpeleg O. The unique neuroradiology of complex I deficiency due to NDUFA12L defect. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">94</span>:78–82.</span> [<a href="/pubmed/18180188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18180188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.b_nit.2001.1344">B&#x000e9;nit P, Chretien D, Kadhom N, de Lonlay-Debeney P, Cormier-Daire V, Cabral A, Peudenier S, Rustin P, Munnich A, Rotig A. Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">68</span>:1344–52.</span> [<a href="/pmc/articles/PMC1226121/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1226121</span></a>] [<a href="/pubmed/11349233" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11349233</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.b_nit.2004.14">B&#x000e9;nit P, Slama A, Cartault F, Giurgea I, Chretien D, Lebon S, Marsac C, Munnich A, Rotig A, Rustin P. Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:14–7.</span> [<a href="/pmc/articles/PMC1757256/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1757256</span></a>] [<a href="/pubmed/14729820" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14729820</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.bourgeron.1995.144">Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, Munnich A, Rotig A. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. <span><span class="ref-journal">Nat Genet. </span>1995;<span class="ref-vol">11</span>:144–9.</span> [<a href="/pubmed/7550341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7550341</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.budde.2000.63">Budde SM, van den Heuvel LP, Janssen AJ, Smeets RJ, Buskens CA, DeMeirleir L, Van Coster R, Baethmann M, Voit T, Trijbels JM, Smeitink JA. Combined enzymatic complex I and III deficiency associated with mutations in the nuclear encoded NDUFS4 gene. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2000;<span class="ref-vol">275</span>:63–8.</span> [<a href="/pubmed/10944442" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10944442</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.calvo.2010.851">Calvo SE, Tucker EJ, Compton AG, Kirby DM, Crawford G, Burtt NP, Rivas M, Guiducci C, Bruno DL, Goldberger OA, Redman MC, Wiltshire E, Wilson CJ, Altshuler D, Gabriel SB, Daly MJ, Thorburn DR, Mootha VK. High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:851–8.</span> [<a href="/pmc/articles/PMC2977978/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2977978</span></a>] [<a href="/pubmed/20818383" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20818383</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.cox.2012.258">Cox R, Platt J, Chen LC, Tang S, Wong LJ, Enns GM. Leigh syndrome caused by a novel m.4296G&#x0003e;A mutation in mitochondrial tRNA isoleucine. <span><span class="ref-journal">Mitochondrion. </span>2012;<span class="ref-vol">12</span>:258–61.</span> [<a href="/pubmed/21982779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21982779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.de_lonlay.2001.57">de Lonlay P, Valnot I, Barrientos A, Gorbatyuk M, Tzagoloff A, Taanman JW, Benayoun E, Chr&#x000e9;tien D, Kadhom N, Lomb&#x000e8;s A, de Baulny HO, Niaudet P, Munnich A, Rustin P, R&#x000f6;tig A. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:57–60.</span> [<a href="/pubmed/11528392" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11528392</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.debray.2007.916">Debray FG, Mitchell GA, Allard P, Robinson BH, Hanley JA, Lambert M. Diagnostic accuracy of blood lactate-to-pyruvate molar ratio in the differential diagnosis of congenital lactic acidosis. <span><span class="ref-journal">Clin Chem. </span>2007;<span class="ref-vol">53</span>:916–21.</span> [<a href="/pubmed/17384007" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17384007</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.debray.2011.183">Debray FG, Morin C, Janvier A, Villeneuve J, Maranda B, Laframboise R, Lacroix J, Decarie JC, Robitaille Y, Lambert M, Robinson BH, Mitchell GA. LRPPRC mutations cause a phenotypically distinct form of Leigh syndrome with cytochrome <em>c</em> oxidase deficiency. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:183–9.</span> [<a href="/pubmed/21266382" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21266382</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.elpeleg.2005.1081">Elpeleg O, Miller C, Hershkovitz E, Bitner-Glindzicz M, Bondi-Rubinstein G, Rahman S, Pagnamenta A, Eshhar S, Saada A. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">76</span>:1081–6.</span> [<a href="/pmc/articles/PMC1196446/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1196446</span></a>] [<a href="/pubmed/15877282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15877282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.fassone.2010.4837">Fassone E, Duncan AJ, Taanman JW, Pagnamenta AT, Sadowski MI, Holand T, Qasim W, Rutland P, Calvo SE, Mootha VK, Bitner-Glindzicz M, Rahman S. FOXRED1, encoding an FAD-dependent oxidoreductase complex-I-specific molecular chaperone, is mutated in infantile-onset mitochondrial encephalopathy. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:4837–47.</span> [<a href="/pmc/articles/PMC4560042/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4560042</span></a>] [<a href="/pubmed/20858599" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20858599</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.fassone.2012.578">Fassone E, Rahman S. Complex I deficiency: clinical features, biochemistry and molecular genetics. <span><span class="ref-journal">J Med Genet. </span>2012;<span class="ref-vol">49</span>:578–90.</span> Erratum in: J Med Genet. 2012;49:668. [<a href="/pubmed/22972949" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22972949</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.fassone.2013.200838">Fassone E, Wedatilake Y, DeVile CJ, Chong WK, Carr LJ, Rahman S. Treatable Leigh-like encephalopathy presenting in adolescence. <span><span class="ref-journal">BMJ Case Rep. </span>2013;<span class="ref-vol">2013</span>:200838.</span> [<a href="/pmc/articles/PMC3822156/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3822156</span></a>] [<a href="/pubmed/24099834" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24099834</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.ferdinandusse.2013.188">Ferdinandusse S, Waterham HR, Heales SJ, Brown GK, Hargreaves IP, Taanman JW, Gunny R, Abulhoul L, Wanders RJ, Clayton PT, Leonard JV, Rahman S. HIBCH mutations can cause Leigh-like disease with combined deficiency of multiple mitochondrial respiratory chain enzymes and pyruvate dehydrogenase. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2013;<span class="ref-vol">8</span>:188.</span> [<a href="/pmc/articles/PMC4222069/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4222069</span></a>] [<a href="/pubmed/24299452" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24299452</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.fernandezmoreira.2007.73">Fernandez-Moreira D, Ugalde C, Smeets R, Rodenburg RJ, Lopez-Laso E, Ruiz-Falco ML, Briones P, Martin MA, Smeitink JA, Arenas J. X-linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy. <span><span class="ref-journal">Ann Neurol. </span>2007;<span class="ref-vol">61</span>:73–83.</span> [<a href="/pubmed/17262856" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17262856</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.gerards.2013.882">Gerards M, Kamps R, van Oevelen J, Boesten I, Jongen E, de Koning B, Scholte HR, de Angst I, Schoonderwoerd K, Sefiani A, Ratbi I, Coppieters W, Karim L, de Coo R, van den Bosch B, Smeets H. Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:882–90.</span> [<a href="/pubmed/23423671" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23423671</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.gerards.2010.507">Gerards M, Sluiter W, van den Bosch BJ, de Wit LE, Calis CM, Frentzen M, Akbari H, Schoonderwoerd K, Scholte HR, Jongbloed RJ, Hendrickx AT, de Coo IF, Smeets HJ. Defective complex I assembly due to C20orf7 mutations as a new cause of Leigh syndrome. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:507–12.</span> [<a href="/pmc/articles/PMC2921275/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2921275</span></a>] [<a href="/pubmed/19542079" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19542079</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.ghezzi.2011.259">Ghezzi D, Arzuffi P, Zordan M, Da Re C, Lamperti C, Benna C, D'Adamo P, Diodato D, Costa R, Mariotti C, Uziel G, Smiderle C, Zeviani M. Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:259–63.</span> [<a href="/pubmed/21278747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21278747</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.ghezzi.2010.639">Ghezzi D, Sevrioukova I, Invernizzi F, Lamperti C, Mora M, D'Adamo P, Novara F, Zuffardi O, Uziel G, Zeviani M. Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">86</span>:639–49.</span> [<a href="/pmc/articles/PMC2850437/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2850437</span></a>] [<a href="/pubmed/20362274" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20362274</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.grafakou.2003.714">Grafakou O, Oexle K, van den Heuvel L, Smeets R, Trijbels F, Goebel HH, Bosshard N, Superti-Furga A, Steinmann B, Smeitink J. Leigh syndrome due to compound heterozygosity of dihydrolipoamide dehydrogenase gene mutations. Description of the first E3 splice site mutation. <span><span class="ref-journal">Eur J Pediatr. </span>2003;<span class="ref-vol">162</span>:714–8.</span> [<a href="/pubmed/12925875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12925875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.haack.2014.342">Haack TB, Gorza M, Danhauser K, Mayr JA, Haberberger B, Wieland T, Kremer L, Strecker V, Graf E, Memari Y, Ahting U, Kopajtich R, Wortmann SB, Rodenburg RJ, Kotzaeridou U, Hoffmann GF, Sperl W, Wittig I, Wilichowski E, Schottmann G, Schuelke M, Plecko B, Stephani U, Strom TM, Meitinger T, Prokisch H, Freisinger P. Phenotypic spectrum of eleven patients and five novel MTFMT mutations identified by exome sequencing and candidate gene screening. <span><span class="ref-journal">Mol Genet Metab. </span>2014;<span class="ref-vol">111</span>:342–52.</span> [<a href="/pubmed/24461907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24461907</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.harding.1992.629">Harding AE, Holt IJ, Sweeney MG, Brockington M, Davis MB. Prenatal diagnosis of mitochondrial DNA8993 T----G disease. <span><span class="ref-journal">Am J Hum Genet. </span>1992;<span class="ref-vol">50</span>:629–33.</span> [<a href="/pmc/articles/PMC1684296/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1684296</span></a>] [<a href="/pubmed/1539598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1539598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.hoefs.2008.1306">Hoefs SJ, Dieteren CE, Distelmaier F, Janssen RJ, Epplen A, Swarts HG, Forkink M, Rodenburg RJ, Nijtmans LG, Willems PH, Smeitink JA, van den Heuvel LP. NDUFA2 complex I mutation leads to Leigh disease. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">82</span>:1306–15.</span> [<a href="/pmc/articles/PMC2427319/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2427319</span></a>] [<a href="/pubmed/18513682" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18513682</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.hoefs.2011.270">Hoefs SJ, van Spronsen FJ, Lenssen EW, Nijtmans LG, Rodenburg RJ, Smeitink JA, van den Heuvel LP. NDUFA10 mutations cause complex I deficiency in a patient with Leigh disease. <span><span class="ref-journal">Eur J Hum Genet. </span>2011;<span class="ref-vol">19</span>:270–4.</span> [<a href="/pmc/articles/PMC3061993/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3061993</span></a>] [<a href="/pubmed/21150889" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21150889</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.imbard.2011.507">Imbard A, Boutron A, Vequaud C, Zater M, de Lonlay P, de Baulny HO, Barnerias C, Min&#x000e9; M, Marsac C, Saudubray JM, Brivet M. Molecular characterization of 82 patients with pyruvate dehydrogenase complex deficiency. Structural implications of novel amino acid substitutions in E1 protein. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">104</span>:507–16.</span> [<a href="/pubmed/21914562" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21914562</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.joost.2010.227">Joost K, Rodenburg R, Piirsoo A, van den Heuvel B, Zordania R, Ounap K. A novel mutation in the SCO2 gene in a neonate with early-onset cardioencephalomyopathy. <span><span class="ref-journal">Pediatr Neurol. </span>2010;<span class="ref-vol">42</span>:227–30.</span> [<a href="/pubmed/20159436" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20159436</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.kaufmann.2006.324">Kaufmann P, Engelstad K, Wei Y, Jhung S, Sano MC, Shungu DC, Millar WS, Hong X, Gooch CL, Mao X, Pascual JM, Hirano M, Stacpoole PW, DiMauro S, De Vivo DC. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">66</span>:324–30.</span> [<a href="/pubmed/16476929" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16476929</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.kirby.2000.102">Kirby DM, Kahler SG, Freckmann ML, Reddihough D, Thorburn DR. Leigh disease caused by the mitochondrial DNA G14459A mutation in unrelated families. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">48</span>:102–4.</span> [<a href="/pubmed/10894222" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10894222</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.kirby.2004.784">Kirby DM, McFarland R, Ohtake A, Dunning C, Ryan MT, Wilson C, Ketteridge D, Turnbull DM, Thorburn DR, Taylor RW. Mutations of the mitochondrial ND1 gene as a cause of MELAS. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:784–9.</span> [<a href="/pmc/articles/PMC1735602/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735602</span></a>] [<a href="/pubmed/15466014" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15466014</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.komaki.2003.293">Komaki H, Akanuma J, Iwata H, Takahashi T, Mashima Y, Nonaka I, Goto Y. A novel mtDNA C11777A mutation in Leigh syndrome. <span><span class="ref-journal">Mitochondrion. </span>2003;<span class="ref-vol">2</span>:293–304.</span> [<a href="/pubmed/16120329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16120329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.lake.2015.482">Lake NJ, Bird MJ, Isohanni P, Paetau A. Leigh syndrome: neuropathology and pathogenesis. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>2015;<span class="ref-vol">74</span>:482–92.</span> [<a href="/pubmed/25978847" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25978847</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.lebon.2003.896">Lebon S, Chol M, Benit P, Mugnier C, Chretien D, Giurgea I, Kern I, Girardin E, Hertz-Pannier L, de Lonlay P, R&#x000f6;tig A, Rustin P, Munnich A. Recurrent de novo mitochondrial DNA mutations in respiratory chain deficiency. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:896–9.</span> [<a href="/pmc/articles/PMC1735336/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735336</span></a>] [<a href="/pubmed/14684687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14684687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.lim.2014.209">Lim SC, Smith KR, Stroud DA, Compton AG, Tucker EJ, Dasvarma A, Gandolfo LC, Marum JE, McKenzie M, Peters HL, Mowat D, Procopis PG, Wilcken B, Christodoulou J, Brown GK, Ryan MT, Bahlo M, Thorburn DR. A founder mutation in PET100 causes isolated complex IV deficiency in Lebanese individuals with Leigh syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2014;<span class="ref-vol">94</span>:209–22.</span> [<a href="/pmc/articles/PMC3928654/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3928654</span></a>] [<a href="/pubmed/24462369" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24462369</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.lissens.2000.209">Lissens W, De Meirleir L, Seneca S, Liebaers I, Brown GK, Brown RM, Ito M, Naito E, Kuroda Y, Kerr DS, Wexler ID, Patel MS, Robinson BH, Seyda A. Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. <span><span class="ref-journal">Hum Mutat. </span>2000;<span class="ref-vol">15</span>:209–19.</span> [<a href="/pubmed/10679936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10679936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.loeffen.2001.195">Loeffen J, Elpeleg O, Smeitink J, Smeets R, St&#x000f6;ckler-Ipsiroglu S, Mandel H, Sengers R, Trijbels F, van den Heuvel L. Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">49</span>:195–201.</span> [<a href="/pubmed/11220739" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11220739</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.loeffen.1998.1598">Loeffen J, Smeitink J, Triepels R, Smeets R, Schuelke M, Sengers R, Trijbels F, Hamel B, Mullaart R, van den Heuvel L. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:1598–608.</span> [<a href="/pmc/articles/PMC1377631/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377631</span></a>] [<a href="/pubmed/9837812" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9837812</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.l_pez.2006.1125">L&#x000f3;pez LC, Schuelke M, Quinzii CM, Kanki T, Rodenburg RJ, Naini A, Dimauro S, Hirano M. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">79</span>:1125–9.</span> [<a href="/pmc/articles/PMC1698707/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1698707</span></a>] [<a href="/pubmed/17186472" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17186472</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.martinelli.2012.383">Martinelli D, Catteruccia M, Piemonte F, Pastore A, Tozzi G, Dionisi-Vici C, Pontrelli G, Corsetti T, Livadiotti S, Kheifets V, Hinman A, Shrader WD, Thoolen M, Klein MB, Bertini E, Miller G. EPI-743 reverses the progression of the pediatric mitochondrial disease--genetically defined Leigh Syndrome. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">107</span>:383–8.</span> [<a href="/pubmed/23010433" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23010433</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.mayr.2011.806">Mayr JA, Freisinger P, Schlachter K, Rolinski B, Zimmermann FA, Scheffner T, Haack TB, Koch J, Ahting U, Prokisch H, Sperl W. Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:806–12.</span> [<a href="/pmc/articles/PMC3234371/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3234371</span></a>] [<a href="/pubmed/22152682" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22152682</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.mcfarland.2002.145">McFarland R, Clark KM, Morris AA, Taylor RW, Macphail S, Lightowlers RN, Turnbull DM. Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation. <span><span class="ref-journal">Nat Genet. </span>2002;<span class="ref-vol">30</span>:145–6.</span> [<a href="/pubmed/11799391" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11799391</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.melegh.1997.257">Melegh B, Trombitas K. Valproate treatment induces lipid globule accumulation with ultrastructural abnormalities of mitochondria in skeletal muscle. <span><span class="ref-journal">Neuropediatrics. </span>1997;<span class="ref-vol">28</span>:257–61.</span> [<a href="/pubmed/9413004" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9413004</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.mineri.2008.473">Mineri R, Rimoldi M, Burlina AB, Koskull S, Perletti C, Heese B, von D&#x000f6;beln U, Mereghetti P, Di Meo I, Invernizzi F, Zeviani M, Uziel G, Tiranti V. Identification of new mutations in the ETHE1 gene in a cohort of 14 patients presenting with ethylmalonic encephalopathy. <span><span class="ref-journal">J Med Genet. </span>2008;<span class="ref-vol">45</span>:473–8.</span> [<a href="/pubmed/18593870" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18593870</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.mitchell.1986.129">Mitchell G, Ogier H, Munnich A, Saudubray JM, Shirrer J, Charpentier C, Rocchiccioli F. Neurological deterioration and lactic acidemia in biotinidase deficiency. A treatable condition mimicking Leigh's disease. <span><span class="ref-journal">Neuropediatrics. </span>1986;<span class="ref-vol">17</span>:129–31.</span> [<a href="/pubmed/3762868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3762868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.niezgoda.2013.785">Niezgoda J, Morgan PG. Anesthetic considerations in patients with mitochondrial defects. <span><span class="ref-journal">Paediatr Anaesth. </span>2013;<span class="ref-vol">23</span>:785–93.</span> [<a href="/pmc/articles/PMC3711963/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3711963</span></a>] [<a href="/pubmed/23534340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23534340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.ohlenbusch.2012.69">Ohlenbusch A, Edvardson S, Skorpen J, Bjornstad A, Saada A, Elpeleg O, G&#x000e4;rtner J, Brockmann K. Leukoencephalopathy with accumulated succinate is indicative of SDHAF1 related complex II deficiency. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2012;2012;<span class="ref-vol">7</span>:69.</span> [<a href="/pmc/articles/PMC3492161/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3492161</span></a>] [<a href="/pubmed/22995659" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22995659</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.oquendo.2004.540">Oquendo CE, Antonicka H, Shoubridge EA, Reardon W, Brown GK. Functional and genetic studies demonstrate that mutation in the COX15 gene can cause Leigh syndrome. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:540–4.</span> [<a href="/pmc/articles/PMC1735852/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735852</span></a>] [<a href="/pubmed/15235026" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15235026</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.ostergaard.2007.853">Ostergaard E, Hansen FJ, Sorensen N, Duno M, Vissing J, Larsen PL, Faeroe O, Thorgrimsson S, Wibrand F, Christensen E, Schwartz M. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:853–61.</span> [<a href="/pubmed/17287286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17287286</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.ostergaard.2011.737">Ostergaard E, Rodenburg RJ, van den Brand M, Thomsen LL, Duno M, Batbayli M, Wibrand F, Nijtmans L. Respiratory chain complex I deficiency due to NDUFA12 mutations as a new cause of Leigh syndrome. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:737–40.</span> [<a href="/pubmed/21617257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21617257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.pagliarini.2008.112">Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, Walford GA, Sugiana C, Boneh A, Chen WK, Hill DE, Vidal M, Evans JG, Thorburn DR, Carr SA, Mootha VK. A mitochondrial protein compendium elucidates complex I disease biology. <span><span class="ref-journal">Cell. </span>2008;<span class="ref-vol">134</span>:112–23.</span> [<a href="/pmc/articles/PMC2778844/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2778844</span></a>] [<a href="/pubmed/18614015" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18614015</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.pagnamenta.2006.214">Pagnamenta AT, Hargreaves IP, Duncan AJ, Taanman JW, Heales SJ, Land JM, Bitner-Glindzicz M, Leonard JV, Rahman S. Phenotypic variability of mitochondrial disease caused by a nuclear mutation in complex II. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">89</span>:214–21.</span> [<a href="/pubmed/16798039" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16798039</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.patel.2012.385">Patel KP, O'Brien TW, Subramony SH, Shuster J, Stacpoole PW. The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">106</span>:385–94.</span> [<a href="/pmc/articles/PMC4003492/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4003492</span></a>] [<a href="/pubmed/22896851" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22896851</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.peters.2014.2903">Peters H, Buck N, Wanders R, Ruiter J, Waterham H, Koster J, Yaplito-Lee J, Ferdinandusse S, Pitt J. ECHS1 mutations in Leigh disease: a new inborn error of metabolism affecting valine metabolism. <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:2903–8.</span> [<a href="/pubmed/25125611" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25125611</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.pitceathly.2013.1795">Pitceathly RD, Rahman S, Wedatilake Y, Polke JM, Cirak S, Foley AR, Sailer A, Hurles ME, Stalker J, Hargreaves I, Woodward CE, Sweeney MG, Muntoni F, Houlden H, Taanman JW, Hanna MG. UK10K Consortium. NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease. <span><span class="ref-journal">Cell Rep. </span>2013;<span class="ref-vol">3</span>:1795–805.</span> [<a href="/pmc/articles/PMC3701321/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3701321</span></a>] [<a href="/pubmed/23746447" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23746447</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.quinonez.2013.67">Quinonez SC, Leber SM, Martin DM, Thoene JG, Bedoyan JK. Leigh syndrome in a girl with a novel DLD mutation causing E3 deficiency. <span><span class="ref-journal">Pediatr Neurol. </span>2013;<span class="ref-vol">48</span>:67–72.</span> [<a href="/pmc/articles/PMC4535688/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4535688</span></a>] [<a href="/pubmed/23290025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23290025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.quintana.2009.s339">Quintana E, Mayr JA, Garc&#x000ed;a Silva MT, Font A, Tortoledo MA, Moliner S, Ozaez L, Lluch M, Cabello A, Ricoy JR, Koch J, Ribes A, Sperl W, Briones P. PDH E(1)beta deficiency with novel mutations in two patients with Leigh syndrome. <span><span class="ref-journal">J Inherit Metab Dis. </span>2009;<span class="ref-vol">32</span> Suppl 1:S339–43.</span> [<a href="/pubmed/19924563" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19924563</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.rahman.1996.343">Rahman S, Blok RB, Dahl HH, Danks DM, Kirby DM, Chow CW, Christodoulou J, Thorburn DR. Leigh syndrome: clinical features and biochemical and DNA abnormalities. <span><span class="ref-journal">Ann Neurol. </span>1996;<span class="ref-vol">39</span>:343–51.</span> [<a href="/pubmed/8602753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8602753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.rahman.2012.76">Rahman S, Clarke CF, Hirano M. 176th ENMC International Workshop: diagnosis and treatment of coenzyme Q10 deficiency. <span><span class="ref-journal">Neuromuscul Disord. </span>2012;<span class="ref-vol">22</span>:76–86.</span> [<a href="/pmc/articles/PMC3222743/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3222743</span></a>] [<a href="/pubmed/21723727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21723727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.sakai.2015.232">Sakai C, Yamaguchi S, Sasaki M, Miyamoto Y, Matsushima Y, Goto Y. ECHS1 mutations cause combined respiratory chain deficiency resulting in Leigh syndrome. <span><span class="ref-journal">Hum Mutat. </span>2015;<span class="ref-vol">36</span>:232–9.</span> [<a href="/pubmed/25393721" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25393721</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.santorelli.1997a.326">Santorelli FM, Tanji K, Kulikova R, Shanske S, Vilarinho L, Hays AP, DiMauro S. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>1997a;<span class="ref-vol">238</span>:326–8.</span> [<a href="/pubmed/9299505" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9299505</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.santorelli.1997b.256">Santorelli FM, Tanji K, Sano M, Shanske S, El-Shahawi M, Kranz-Eble P, DiMauro S, De Vivo DC. Maternally inherited encephalopathy associated with a single-base insertion in the mitochondrial tRNATrp gene. <span><span class="ref-journal">Ann Neurol. </span>1997b;<span class="ref-vol">42</span>:256–60.</span> [<a href="/pubmed/9266739" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9266739</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.schiff.2006.709">Schiff M, Min&#x000e9; M, Brivet M, Marsac C, Elmaleh-Berg&#x000e9;s M, Evrard P, Ogier de Baulny H. Leigh's disease due to a new mutation in the PDHX gene. <span><span class="ref-journal">Ann Neurol. </span>2006;<span class="ref-vol">59</span>:709–14.</span> [<a href="/pubmed/16566017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16566017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.schwartzentruber.2014.1285">Schwartzentruber J, Buhas D, Majewski J, Sasarman F, Papillon-Cavanagh S, Thiffault I, Sheldon KM, Massicotte C, Patry L, Simon M, Zare AS, McKernan KJ., FORGE Canada Consortium.  Michaud J, Boles RG, Deal CL, Desilets V, Shoubridge EA, Samuels ME. Mutation in the nuclear-encoded mitochondrial isoleucyl-tRNA synthetase IARS2 in patients with cataracts, growth hormone deficiency with short stature, partial sensorineural deafness, and peripheral neuropathy or with Leigh syndrome. <span><span class="ref-journal">Hum Mutat. </span>2014;<span class="ref-vol">35</span>:1285–9.</span> [<a href="/pubmed/25130867" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25130867</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.shamseldin.2012.234">Shamseldin HE, Alshammari M, Al-Sheddi T, Salih MA, Alkhalidi H, Kentab A, Repetto GM, Hashem M, Alkuraya FS. Genomic analysis of mitochondrial diseases in a consanguineous population reveals novel candidate disease genes. <span><span class="ref-journal">J Med Genet. </span>2012;<span class="ref-vol">49</span>:234–41.</span> [<a href="/pubmed/22499341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22499341</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.shear.2004.792">Shear T, Tobias JD. Anesthetic implications of Leigh's syndrome. <span><span class="ref-journal">Paediatr Anaesth. </span>2004;<span class="ref-vol">14</span>:792–7.</span> [<a href="/pubmed/15330965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15330965</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.soreze.2013.192">Soreze Y, Boutron A, Habarou F, Barnerias C, Nonnenmacher L, Delpech H, Mamoune A, Chr&#x000e9;tien D, Hubert L, Bole-Feysot C, Nitschke P, Correia I, Sardet C, Boddaert N, Hamel Y, Delahodde A, Ottolenghi C, de Lonlay P. Mutations in human lipoyltransferase gene LIPT1 cause a Leigh disease with secondary deficiency for pyruvate and alpha-ketoglutarate dehydrogenase. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2013;<span class="ref-vol">8</span>:192.</span> [<a href="/pmc/articles/PMC3905285/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3905285</span></a>] [<a href="/pubmed/24341803" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24341803</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.spiegel.2009.419">Spiegel R, Shaag A, Edvardson S, Mandel H, Stepensky P, Shalev SA, Horovitz Y, Pines O, Elpeleg O. SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis. <span><span class="ref-journal">Ann Neurol. </span>2009;<span class="ref-vol">66</span>:419–24.</span> [<a href="/pubmed/19798730" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19798730</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.stacpoole.2008.e1223">Stacpoole PW, Gilbert LR, Neiberger RE, Carney PR, Valenstein E, Theriaque DW, Shuster JJ. Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate. <span><span class="ref-journal">Pediatrics. </span>2008;<span class="ref-vol">121</span>:e1223–8.</span> [<a href="/pmc/articles/PMC3777225/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3777225</span></a>] [<a href="/pubmed/18411236" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18411236</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.sugiana.2008.468">Sugiana C, Pagliarini DJ, McKenzie M, Kirby DM, Salemi R, Abu-Amero KK, Dahl HH, Hutchison WM, Vascotto KA, Smith SM, Newbold RF, Christodoulou J, Calvo S, Mootha VK, Ryan MT, Thorburn DR. Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">83</span>:468–78.</span> [<a href="/pmc/articles/PMC2561934/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2561934</span></a>] [<a href="/pubmed/18940309" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18940309</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.taanman.2009.248">Taanman JW, Rahman S, Pagnamenta AT, Morris AA, Bitner-Glindzicz M, Wolf NI, Leonard JV, Clayton PT, Schapira AH. Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA depletion. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:248–54.</span> [<a href="/pubmed/18828154" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18828154</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.taylor.2014.68">Taylor RW, Pyle A, Griffin H, Blakely EL, Duff J, He L, Smertenko T, Alston CL, Neeve VC, Best A, Yarham JW, Kirschner J, Schara U, Talim B, Topaloglu H, Baric I, Holinski-Feder E, Abicht A, Czermin B, Kleinle S, Morris AA, Vassallo G, Gorman GS, Ramesh V, Turnbull DM, Santibanez-Koref M, McFarland R, Horvath R, Chinnery PF. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. <span><span class="ref-journal">JAMA. </span>2014;<span class="ref-vol">312</span>:68–77.</span> [<a href="/pmc/articles/PMC6558267/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6558267</span></a>] [<a href="/pubmed/25058219" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25058219</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.tiranti.2000.2733">Tiranti V, Corona P, Greco M, Taanman JW, Carrara F, Lamantea E, Nijtmans L, Uziel G, Zeviani M. A novel frameshift mutation of the mtDNA COIII gene leads to impaired assembly of cytochrome c oxidase in a patient affected by Leigh-like syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:2733–42.</span> [<a href="/pubmed/11063732" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11063732</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.tort.2014.1907">Tort F, Ferrer-Cort&#x000e8;s X, Thi&#x000f3; M, Navarro-Sastre A, Matalonga L, Quintana E, Bujan N, Arias A, Garc&#x000ed;a-Villoria J, Acquaviva C, Vianey-Saban C, Artuch R, Garc&#x000ed;a-Cazorla &#x000c0;, Briones P, Ribes A. Mutations in the lipoyltransferase LIPT1 gene cause a fatal disease associated with a specific lipoylation defect of the 2-ketoacid dehydrogenase complexes. <span><span class="ref-journal">Hum Mol Genet. </span>2014;<span class="ref-vol">23</span>:1907–15.</span> [<a href="/pubmed/24256811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24256811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.triepels.1999.787">Triepels RH, van den Heuvel LP, Loeffen JL, Buskens CA, Smeets RJ, Rubio Gozalbo ME, Budde SM, Mariman EC, Wijburg FA, Barth PG, Trijbels JM, Smeitink JA. Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. <span><span class="ref-journal">Ann Neurol. </span>1999;<span class="ref-vol">45</span>:787–90.</span> [<a href="/pubmed/10360771" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10360771</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.tucker.2011.428">Tucker EJ, Hershman SG, K&#x000f6;hrer C, Belcher-Timme CA, Patel J, Goldberger OA, Christodoulou J, Silberstein JM, McKenzie M, Ryan MT, Compton AG, Jaffe JD, Carr SA, Calvo SE. RajBhandary UL, Thorburn DR, Mootha VK. Mutations in MTFMT underlie a human disorder of formylation causing impaired mitochondrial translation. <span><span class="ref-journal">Cell Metab. </span>2011;<span class="ref-vol">14</span>:428–34.</span> [<a href="/pmc/articles/PMC3486727/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3486727</span></a>] [<a href="/pubmed/21907147" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21907147</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.ugalde.2007.10">Ugalde C, Hinttala R, Timal S, Smeets R, Rodenburg RJ, Uusimaa J, van Heuvel LP, Nijtmans LG, Majamaa K, Smeitink JA. Mutated ND2 impairs mitochondrial complex I assembly and leads to Leigh syndrome. <span><span class="ref-journal">Mol Genet Metab. </span>2007;<span class="ref-vol">90</span>:10–4.</span> [<a href="/pubmed/16996290" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16996290</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.valente.2007.44">Valente L, Tiranti V, Marsano RM, Malfatti E, Fernandez-Vizarra E, Donnini C, Mereghetti P, De Gioia L, Burlina A, Castellan C, Comi GP, Savasta S, Ferrero I, Zeviani M. Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">80</span>:44–58.</span> [<a href="/pmc/articles/PMC1785320/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1785320</span></a>] [<a href="/pubmed/17160893" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17160893</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.van_den_bosch.2012.10">van den Bosch BJ, Gerards M, Sluiter W, Stegmann AP, Jongen EL, Hellebrekers DM, Oegema R, Lambrichs EH, Prokisch H, Danhauser K, Schoonderwoerd K, de Coo IF, Smeets HJ. Defective NDUFA9 as a novel cause of neonatally fatal complex I disease. <span><span class="ref-journal">J Med Genet. </span>2012;<span class="ref-vol">49</span>:10–5.</span> [<a href="/pubmed/22114105" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22114105</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.van_hove.2010.159">Van Hove JL, Saenz MS, Thomas JA, Gallagher RC, Lovell MA, Fenton LZ, Shanske S, Myers SM, Wanders RJ, Ruiter J, Turkenburg M, Waterham HR. Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy. <span><span class="ref-journal">Pediatr Res. </span>2010;<span class="ref-vol">68</span>:159–64.</span> [<a href="/pmc/articles/PMC2928220/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2928220</span></a>] [<a href="/pubmed/20453710" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20453710</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.vedrenne.2012.912">Vedrenne V, Gowher A, de Lonlay P, Nitschke P, Serre V, Boddaert N, Altuzarra C, Mager-Heckel AM, Chretien F, Entelis N, Munnich A, Tarassov I, R&#x000f6;tig A. Mutation in PNPT1, which encodes a polyribonucleotide nucleotidyltransferase, impairs RNA import into mitochondria and causes respiratory-chain deficiency. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">91</span>:912–8.</span> [<a href="/pmc/articles/PMC3487136/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3487136</span></a>] [<a href="/pubmed/23084291" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23084291</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.wedatilake.2013.96">Wedatilake Y, Brown RM, McFarland R, Yaplito-Lee J, Morris AA, Champion M, Jardine PE, Clarke A, Thorburn DR, Taylor RW, Land JM, Forrest K, Dobbie A, Simmons L, Aasheim ET, Ketteridge D, Hanrahan D, Chakrapani A, Brown GK, Rahman S. SURF1 deficiency: a multi-centre natural history study. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2013;<span class="ref-vol">8</span>:96.</span> [<a href="/pmc/articles/PMC3706230/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3706230</span></a>] [<a href="/pubmed/23829769" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23829769</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.weraarpachai.2009.833">Weraarpachai W, Antonicka H, Sasarman F, Seeger J, Schrank B, Kolesar JE, Lochm&#x000fc;ller H, Chevrette M, Kaufman BA, Horvath R, Shoubridge EA. Mutation in TACO1, encoding a translational activator of COX I, results in cytochrome <em>c</em> oxidase deficiency and late-onset Leigh syndrome. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:833–7.</span> [<a href="/pubmed/19503089" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19503089</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leigh-nucl-ov.REF.wortmann.2012.797">Wortmann SB, Vaz FM, Gardeitchik T, Vissers LE, Renkema GH, Schuurs-Hoeijmakers JH, Kulik W, Lammens M, Christin C, Kluijtmans LA, Rodenburg RJ, Nijtmans LG, Gr&#x000fc;newald A, Klein C, Gerhold JM, Kozicz T, van Hasselt PM, Harakalova M, Kloosterman W, Bari&#x00107; I, Pronicka E, Ucar SK, Naess K, Singhal KK, Krumina Z, Gilissen C, van Bokhoven H, Veltman JA, Smeitink JA, Lefeber DJ, Spelbrink JN, Wevers RA, Morava E, de Brouwer AP. Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:797–802.</span> [<a href="/pubmed/22683713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22683713</span></a>]</div></li></ul></div></div><div id="leigh-nucl-ov.Chapter_Notes"><h2 id="_leigh-nucl-ov_Chapter_Notes_">Chapter Notes</h2><div id="leigh-nucl-ov.Author_Notes"><h3>Author Notes</h3><p><a href="https://iris.ucl.ac.uk/iris/browse/profile?upi=SRAHM75" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Professor Rahman's web page</a></p><p><a href="https://www.mcri.edu.au/users/professor-david-thorburn" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Professor Thorburn's web page</a></p><p>Professor Rahman's research interests include identification of novel nuclear genes causing mitochondrial disease, using a combination of approaches including homozygosity mapping and <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> and genome <a class="def" href="/books/n/gene/glossary/def-item/next-generation-sequencing/">next-generation sequencing</a>. Her group has identified a number of nuclear genes causing childhood-onset mitochondrial disorders, including genes involved in mitochondrial DNA maintenance and expression, complex I and complex IV function and biosynthesis of coenzyme Q<sub>10</sub>. Other research interests aim to identify biomarkers and novel therapies for childhood mitochondrial disorders.</p><p>David Thorburn's research focuses on improving diagnosis, prevention and treatment of mitochondrial energy generation disorders. This has included translating knowledge of mitochondrial DNA genetics into reproductive options for families, defining diagnostic criteria and epidemiology and discovery of new "disease" genes through next-generation DNA sequencing. His group also uses cellular and mouse models to understand pathogenic mechanisms and trial new treatment approaches.</p></div><div id="leigh-nucl-ov.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>1 October 2015 (me) Review posted live</div></li><li class="half_rhythm"><div>17 February 2015 (sr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK320989</span><span class="label">PMID: <a href="/pubmed/26425749" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">26425749</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/leopard/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mga3/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK320989&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK320989/?report=reader">PubReader</a></li><li><a href="/books/NBK320989/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK320989" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK320989" style="display:none" title="Cite this Page"><div class="bk_tt">Rahman S, Thorburn D. Nuclear Gene-Encoded Leigh Syndrome Overview. 2015 Oct 1. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK320989/pdf/Bookshelf_NBK320989.pdf">PDF version of this page</a> (523K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#leigh-nucl-ov.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#leigh-nucl-ov.Definition" ref="log$=inpage&amp;link_id=inpage">Definition</a></li><li><a href="#leigh-nucl-ov.Causes" ref="log$=inpage&amp;link_id=inpage">Causes</a></li><li><a href="#leigh-nucl-ov.Evaluation_Strategy" ref="log$=inpage&amp;link_id=inpage">Evaluation Strategy</a></li><li><a href="#leigh-nucl-ov.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#leigh-nucl-ov.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#leigh-nucl-ov.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#leigh-nucl-ov.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#leigh-nucl-ov.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1355[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COX15</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=51204[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TACO1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4570[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TN</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=617[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">BCS1L</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=22868[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FASTKD2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1352[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COX10</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6389[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SDHA</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=116228[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COX20</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84334[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COA8</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4574[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TS1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=100131801[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PET100</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84987[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COX14</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1351[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COX8A</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6834[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SURF1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6341[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SCO1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1340[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COX6B1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4123878" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4123878" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301352" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial DNA-Associated Leigh Syndrome and NARP</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial DNA-Associated Leigh Syndrome and NARP<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Thorburn DR, Rahman J, Rahman S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301403" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial Disorders Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial Disorders Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chinnery PF. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301411" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> MELAS</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> MELAS<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">El-Hattab AW, Almannai M, Scaglia F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28125198" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Primary Coenzyme Q<sub xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">10</sub> Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Primary Coenzyme Q<sub xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">10</sub> Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Salviati L, Trevisson E, Doimo M, Navas P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301353" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leber Hereditary Optic Neuropathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leber Hereditary Optic Neuropathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yu-Wai-Man P, Chinnery PF. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=26425749" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=26425749" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041977dde08911694d412f">Nuclear Gene-Encoded Leigh Syndrome Overview - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Nuclear Gene-Encoded Leigh Syndrome Overview - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:22:47-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89D400E0417511000000000113007D&amp;ncbi_session=CE89D400E0419771_0275SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK320989%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK320989&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK320989/&amp;ncbi_pagename=Nuclear Gene-Encoded Leigh Syndrome Overview - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89D400E0419771_0275SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>